Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design

Abstract
This Opinion article describes the newly discovered conserved immunological and structural features of the sequence-variable regions of HIV-1 gp120, which the authors suggest warrant the reappraisal of these regions as vaccine targets. One of the main challenges of developing an HIV-1 vaccine lies in eliciting immune responses that can overcome the antigenic variability exhibited by HIV. Most HIV-1 vaccine development has focused on inducing immunity to conserved regions of the HIV-1 envelope. However, new studies of the sequence-variable regions of the HIV-1 gp120 envelope glycoprotein have shown that there are conserved immunological and structural features in these regions. Recombinant immunogens that include these features may provide the means to address the antigenic diversity of HIV-1 and induce protective antibodies that can prevent infection with HIV-1.

This publication has 133 references indexed in Scilit: